Biosynergy Inc Revenue Growth Rates (BSYN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biosynergy Inc  (BSYN)
 

BSYN's Revenue Growth by Quarter and Year

Biosynergy Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSYN Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter April -
3rd Quarter January 0.33
2nd Quarter October 0.52
1st Quarter July 0.17
FY 1.02





BSYN Revenue third quarter 2022 Y/Y Growth Comment
Biosynergy Inc reported fall in Revenue in the third quarter 2022 by -38.48% to $ 0.33 millions, from the same quarter in 2021.
The drop in the third quarter 2022 Biosynergy Inc's Revenue compares unfavorably to the Company's average Revenue growth of 5.75%.

Looking into third quarter 2022 results within Scientific & Technical Instruments industry 14 other companies have achieved higher Revenue growth. While Biosynergy Inc' s Revenue drop of -38.48% ranks overall at the positon no. 3493 in the third quarter 2022.


BSYN Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter April - - 18.52 % -
3rd Quarter January -38.48 % 82.76 % -61.33 % 134.38 %
2nd Quarter October -17.46 % 103.23 % -6.06 % 10 %
1st Quarter July -70.69 % 81.25 % 0 % 3.23 %
FY   - -5.65 % -25.75 % -

Financial Statements
Biosynergy Inc's third quarter 2022 Revenue $ 0.33 millions BSYN's Income Statement
Biosynergy Inc's third quarter 2021 Revenue $ 0.53 millions Quarterly BSYN's Income Statement


BSYN Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter April - - 10.34 % -64 %
3rd Quarter January -37.3 % -15.87 % -6.45 % 127.27 %
2nd Quarter October 205.88 % 8.62 % -3.13 % 3.13 %
1st Quarter July - 81.25 % 18.52 % -
FY (Year on Year)   - -5.65 % -25.75 % -


Back to BSYN Growth rate Comparisons >> Back to BSYN Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry #15
Technology Sector #554
Overall #3493

Revenue Y/Y Growth Statistics
High Average Low
100.77 % 5.75 % -70.01 %
(Oct 31 2020)   (Jul 31 2021)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry #15
Technology Sector #554
Overall #3493
Revenue Y/Y Growth Statistics
High Average Low
100.77 % 5.75 % -70.01 %
(Oct 31 2020)   (Jul 31 2021)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Biosynergy Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
198.57 % 9.33 % -37.54 %
(Oct 31 2021)  


BSYN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Biosynergy Inc disclosed fall in Revenue from the second quarter by -37.3% to $ 0.33 millions, from $ 0.52 millions achived in the previous reporting period.

But that's not important problem, as Biosynergy Inc's Revenue generally seem to plunge in this quarter.

Within Scientific & Technical Instruments industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Biosynergy Inc's Revenue growth quarter on quarter, overall rank is 3703.


Revenue Q/Q Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry #15
Technology Sector #581
Overall #3703
Revenue Q/Q Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry #15
Technology Sector #581
Overall #3703
Revenue Q/Q Growth Statistics
High Average Low
198.57 % 9.33 % -37.54 %
(Oct 31 2021)  


BSYN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Biosynergy Inc disclosed fall in Revenue from the second quarter by -37.3% to $ 0.33 millions, from $ 0.52 millions achived in the previous reporting period.

But that's not important problem, as Biosynergy Inc's Revenue generally seem to plunge in this quarter.

Within Scientific & Technical Instruments industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Biosynergy Inc's Revenue growth quarter on quarter, overall rank is 3703.


Biosynergy Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jan 31 2022)		 12 Months Ending
(Oct 31 2021)		 12 Months Ending
(Jul 31 2021)		 12 Months Ending
(Apr 30 2021)		 12 Months Ending
(Jan 31 2021)
Cumulative Revenue 12 Months Ending $ 0.46 $ 0.66 $ 0.77 $ 1.17 $ 2.06
Y / Y Revenue Growth (TTM) -77.83 % -63.7 % -49.11 % -5.19 % 72.37 %
Year on Year Revenue Growth Overall Ranking # 702 # 3465 # 3505 # 450 # 164
Seqeuential Revenue Change (TTM) -30.93 % -13.72 % -34.78 % -42.97 % 13.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 2402 # 3584 # 3805 # 3814 # 370


Cumulative Revenue growth Comment
Biosynergy Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -77.83% year on year, at Jan 31 2022 compare to the -63.7% decrease at Oct 31 2021. If the Biosynergy Inc's fiscal year would end at Jan 31 2022, annual Revenue would be $0 millions.

In the Technology sector 85 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 3465.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry # 12
Technology Sector # 86
Overall # 702

Revenue TTM Y/Y Growth Statistics
High Average Low
56.61 %
 -3.27 %
-77.56 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 368
S&P 500 # 2402
Cumulative Revenue growth Comment
Biosynergy Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -77.83% year on year, at Jan 31 2022 compare to the -63.7% decrease at Oct 31 2021. If the Biosynergy Inc's fiscal year would end at Jan 31 2022, annual Revenue would be $0 millions.

In the Technology sector 85 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 3465.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Scientific & Technical Instruments Industry # 12
Technology Sector # 86
Overall # 702

Revenue TTM Y/Y Growth Statistics
High Average Low
56.61 %
-3.27 %
-77.56 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 368
S&P 500 # 2402




Other Revenue Growth
Scientific & Technical Instruments Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BSYN's Revenue Growth Ratio versus Scientific & Technical Instruments Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jan 31 2022 within Technology SectorY/Y Change %Revenue for the quarter ending Jan 31 2022
Methode Electronics Inc -1.25%$ -1.253 millions
Plexus Corp -1.55%$ -1.553 millions
Skywater Technology Inc -3.12%$ -3.115 millions
Secureworks Corp-8.48%$ -8.485 millions
Duesenberg Technologies Inc -8.95%$ -8.947 millions
Red Cat Holdings Inc -13.48%$ -13.478 millions
PINEAPPLE EXPRESS CANNABIS Co-13.56%$ -13.559 millions
Silicon Laboratories Inc -14.09%$ -14.094 millions
Comtech Telecommunications Corp-25.36%$ -25.365 millions
Verint Systems Inc-32.92%$ -32.922 millions
Biosynergy Inc-38.51%$ -38.507 millions
Netapp Inc -45.85%$ -45.850 millions


About Biosynergy Inc Revenue Growth Rates (BSYN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biosynergy Inc (CIK 715812).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-22-007349
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biosynergy Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.